Short description
BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.
Description
BioSenic is a forward-thinking firm that aims to address critical unmet medical needs in the fields of innate immunity, inflammation, and organ/function repair.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Belgium, Wisconsin, United States, North America
Founded on
October 1, 2022
Exited on
October 27, 2022
Went public on
October 27, 2022
Stock symbol
BIOS
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noway Youcantaccess
Sign in for full access
Founders
Carole Nicco